Overview

Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets

Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
To Evaluate the Tolerability and Pharmacokinetics of GST-HG141 Tablets in Single-center, Randomized, Double-blind, Placebo-controlled Multiple-dose, Single-dose, Multiple-dose Phase Ia Clinical Trials in Healthy Subjects .
Phase:
Phase 1
Details
Lead Sponsor:
Fujian Cosunter Pharmaceutical Co. Ltd